Unilever PLC Response to press reporting (5544Y)
17 Gennaio 2022 - 8:00AM
UK Regulatory
TIDMULVR
RNS Number : 5544Y
Unilever PLC
17 January 2022
Response to press reporting
London, 15 January 2022. Unilever notes recent reporting
regarding its interest in GSK Consumer Healthcare and confirms that
it has approached GSK and Pfizer about a potential acquisition of
the business.
GSK Consumer Healthcare is a leader in the attractive consumer
health space and would be a strong strategic fit as Unilever
continues to re-shape its portfolio.
There can be no certainty that any agreement will be
reached.
ENDS
This communication contains inside information. This is a public
announcement pursuant to Article 17 paragraph 1 of the European
Market Abuse Regulation (596/2014), including as applied in the
UK.
Safe Harbour
This announcement may contain forward-looking statements,
including 'forward-looking statements' within the meaning of the
United States Private Securities Litigation Reform Act of 1995.
Words such as 'will', 'aim', 'expects', 'anticipates', 'intends',
'looks', 'believes', 'vision', or the negative of these terms and
other similar expressions of future performance or results, and
their negatives, are intended to identify such forward-looking
statements. These forward-looking statements are based upon current
expectations and assumptions regarding anticipated developments and
other factors affecting the Unilever Group (the 'Group'). They are
not historical facts, nor are they guarantees of future
performance.
Because these forward-looking statements involve risks and
uncertainties, there are important factors that could cause actual
results to differ materially from those expressed or implied by
these forward-looking statements. Among other risks and
uncertainties, the material or principal factors which could cause
actual results to differ materially are: Unilever's global brands
not meeting consumer preferences; Unilever's ability to innovate
and remain competitive; Unilever's investment choices in its
portfolio management; the effect of climate change on Unilever's
business; Unilever's ability to find sustainable solutions to its
plastic packaging; significant changes or deterioration in customer
relationships; the recruitment and retention of talented employees;
disruptions in our supply chain and distribution; increases or
volatility in the cost of raw materials and commodities; the
production of safe and high quality products; secure and reliable
IT infrastructure; execution of acquisitions, divestitures and
business transformation projects; economic, social and political
risks and natural disasters; financial risks; failure to meet high
and ethical standards; and managing regulatory, tax and legal
matters. A number of these risks have increased as a result of the
current Covid-19 pandemic. These forward-looking statements speak
only as of the date of this document. Except as required by any
applicable law or regulation, the Group expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein to
reflect any change in the Group's expectations with regard thereto
or any change in events, conditions or circumstances on which any
such statement is based.
Further details of potential risks and uncertainties affecting
the Group are described in the Group's filings with the London
Stock Exchange, Euronext Amsterdam and the US Securities and
Exchange Commission, including in the Annual Report on Form 20-F
2020 and the Unilever Annual Report and Accounts 2020 available on
our corporate website.
Enquiries
Media:
Jonathan Sibun +44 77 7999 9683 / JSibun@tulchangroup.com
Lucila Zambrano +44 78 2527 3767 /
lucila.zambrano@unilever.com
Investors: Investor Relations Team
+44 20 7822 6830
investor.relations@unilever.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
SPCEAFFSFASAEFA
(END) Dow Jones Newswires
January 17, 2022 02:00 ET (07:00 GMT)
Grafico Azioni Unilever (LSE:ULVR)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Unilever (LSE:ULVR)
Storico
Da Apr 2023 a Apr 2024
